Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 1/2011

01.02.2011 | Original Article

Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations

verfasst von: Ulrike Schara, Jürgen-Christoph von Kleist-Retzow, Elke Lainka, Patrick Gerner, Angela Pyle, Paul M. Smith, Hanns Lochmüller, Birgit Czermin, Angela Abicht, Elke Holinski-Feder, Rita Horvath

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Combined respiratory chain deficiency accounts for about 30% of mitochondrial respiratory chain deficiencies and is frequently associated with mtDNA depletion, deletions or point mutations. However combined respiratory chain deficiency may also be caused by mutations in nuclear genes affecting mitochondrial translation. Here we describe a 2-year-old girl, who developed an acute, isolated, severe liver failure with mitochondrial pathology and decreased respiratory chain enzyme activities both in liver and skeletal muscle at 4 months of age. Her liver function improved significantly within a month, liver function tests returned to normal. Liver cirrhosis remained without any further complications so far. Pathogenic compound heterozygous mutations were identified in the TRMU gene. This condition is one of the few mitochondrial disorders with a life-threatening onset showing recovery later in life, therefore a prompt diagnosis and treatment of these patients has great importance in clinical practice. We suggest that TRMU deficiency should be considered in infants with acute liver disease.
Literatur
Zurück zum Zitat Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA (2006) The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 15:1835–1846CrossRefPubMed Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA (2006) The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 15:1835–1846CrossRefPubMed
Zurück zum Zitat Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308CrossRefPubMed Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308CrossRefPubMed
Zurück zum Zitat Coenen MJ, Antonicka H, Ugalde C et al. (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 351:2080–2086CrossRefPubMed Coenen MJ, Antonicka H, Ugalde C et al. (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 351:2080–2086CrossRefPubMed
Zurück zum Zitat Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M (2007) Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA). J Med Genet 44:173–180CrossRefPubMed Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M (2007) Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA). J Med Genet 44:173–180CrossRefPubMed
Zurück zum Zitat Guan MX, Yan Q, Li X et al. (2006) Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet 79:291–302CrossRefPubMed Guan MX, Yan Q, Li X et al. (2006) Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet 79:291–302CrossRefPubMed
Zurück zum Zitat Horvath R, Kemp JP, Tuppen HA et al. (2009) Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 132:3165–3174CrossRefPubMed Horvath R, Kemp JP, Tuppen HA et al. (2009) Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 132:3165–3174CrossRefPubMed
Zurück zum Zitat Jacobs HT, Turnbull DM (2005) Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 21:312–314CrossRefPubMed Jacobs HT, Turnbull DM (2005) Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 21:312–314CrossRefPubMed
Zurück zum Zitat Levinger L, Mörl M, Florentz C (2004) Mitochondrial tRNA 3′end metabolism and human disease. Nucl Acids Res 32:5430–5441CrossRefPubMed Levinger L, Mörl M, Florentz C (2004) Mitochondrial tRNA 3′end metabolism and human disease. Nucl Acids Res 32:5430–5441CrossRefPubMed
Zurück zum Zitat Miller C, Saada A, Shaul N et al. (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734–738CrossRefPubMed Miller C, Saada A, Shaul N et al. (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734–738CrossRefPubMed
Zurück zum Zitat Montero R, Sánchez-Alcázar JA, Briones P et al. (2009) Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report. Clin Biochem 42:742–745CrossRefPubMed Montero R, Sánchez-Alcázar JA, Briones P et al. (2009) Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report. Clin Biochem 42:742–745CrossRefPubMed
Zurück zum Zitat Riley LG, Cooper S, Hickey P et al. (2010) Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia–MLASA syndrome. Am J Hum Genet 87:52–59CrossRefPubMed Riley LG, Cooper S, Hickey P et al. (2010) Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia–MLASA syndrome. Am J Hum Genet 87:52–59CrossRefPubMed
Zurück zum Zitat Saada A, Shaag A, Arnon S et al. (2007) Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J Med Genet 44:784–786CrossRefPubMed Saada A, Shaag A, Arnon S et al. (2007) Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation. J Med Genet 44:784–786CrossRefPubMed
Zurück zum Zitat Sacconi S, Trevisson E, Salviati L et al. (2010) Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 20:44–48CrossRefPubMed Sacconi S, Trevisson E, Salviati L et al. (2010) Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 20:44–48CrossRefPubMed
Zurück zum Zitat Sarzi E, Bourdon A, Chrétien D et al. (2007) Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J Pediatr 150:531–534CrossRefPubMed Sarzi E, Bourdon A, Chrétien D et al. (2007) Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J Pediatr 150:531–534CrossRefPubMed
Zurück zum Zitat Smeitink JA, Elpeleg O, Antonicka H et al. (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869–877CrossRefPubMed Smeitink JA, Elpeleg O, Antonicka H et al. (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869–877CrossRefPubMed
Zurück zum Zitat Smits P, Mattijssen S, Morava E et al. (2010a) Functional consequences of mitochondrial tRNA Trp and tRNA Arg mutations causing combined OXPHOS defects. Eur J Hum Genet 18:324–329CrossRefPubMed Smits P, Mattijssen S, Morava E et al. (2010a) Functional consequences of mitochondrial tRNA Trp and tRNA Arg mutations causing combined OXPHOS defects. Eur J Hum Genet 18:324–329CrossRefPubMed
Zurück zum Zitat Smits P, Smeitink J, van den Heuvel L (2010b) Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010:737385PubMed Smits P, Smeitink J, van den Heuvel L (2010b) Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010:737385PubMed
Zurück zum Zitat Spinazzola A, Invernizzi F, Carrara F et al. (2009) Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 32:143–158CrossRefPubMed Spinazzola A, Invernizzi F, Carrara F et al. (2009) Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 32:143–158CrossRefPubMed
Zurück zum Zitat Tuppen HA, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 1797:113–128PubMed Tuppen HA, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 1797:113–128PubMed
Zurück zum Zitat Valente L, Tiranti V, Marsano RM et al. (2007) Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet 80:44–58CrossRefPubMed Valente L, Tiranti V, Marsano RM et al. (2007) Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet 80:44–58CrossRefPubMed
Zurück zum Zitat Yan Q, Bykhovskaya Y, Li R et al. (2006) Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase is a putative nuclear modifier gene for the phenotypic expression of the deafness-associated 12S rRNA mutations. Biochem Biophys Res Commun 342:1130–1136CrossRefPubMed Yan Q, Bykhovskaya Y, Li R et al. (2006) Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase is a putative nuclear modifier gene for the phenotypic expression of the deafness-associated 12S rRNA mutations. Biochem Biophys Res Commun 342:1130–1136CrossRefPubMed
Zurück zum Zitat Zeharia A, Shaag A, Pappo O et al. (2009) Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 85:401–407CrossRefPubMed Zeharia A, Shaag A, Pappo O et al. (2009) Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 85:401–407CrossRefPubMed
Metadaten
Titel
Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations
verfasst von
Ulrike Schara
Jürgen-Christoph von Kleist-Retzow
Elke Lainka
Patrick Gerner
Angela Pyle
Paul M. Smith
Hanns Lochmüller
Birgit Czermin
Angela Abicht
Elke Holinski-Feder
Rita Horvath
Publikationsdatum
01.02.2011
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 1/2011
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9250-z

Weitere Artikel der Ausgabe 1/2011

Journal of Inherited Metabolic Disease 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.